New York Life Investment Management »

Mirati Therapeutics shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $15M 256k 58.75

More positions owned by New York Life Investment Management

Apple (AAPL)
Microsoft Corporation (MSFT)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Amazon (AMZN)
Indexiq Etf Tr Candriam Us Mid (IQSM)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Interna (IQSI)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Mirati Therapeutics

EcoR1 Capital
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Boxer Capital
Sawtooth Asset Management
Braslyn
Alpine Associates Management
Tang Capital Management
Paradigm Biocapital Advisors
Pentwater Capital Management
CSS
Hsbc Holdings
Norges Bank Investment Management
Alliancebernstein

View all funds holding Mirati Therapeutics